Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease
This study is ongoing, but not recruiting participants.
Sponsor:
University of Bern
Collaborators:
University Hospital, Basel, Switzerland
University of Lausanne Hospitals
Swiss IBD Cohort Study
MSD Merck Sharp & Dohme AG
Information provided by:
University of Bern
ClinicalTrials.gov Identifier:
NCT01473927
First received: November 3, 2011
Last updated: February 6, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |